镰状细胞病
危机预防
药物诱导胎儿血红蛋白
Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (打开新窗口)
来源: Ann Intern Med 2008;148(12):939-55.
检索: PubMed 18458272
Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (打开新窗口)
来源: Am J Hematol 2000;64(1):26-31.
检索: PubMed 10815784
Hydroxyurea for the treatment of sickle cell anemia. (打开新窗口)
来源: N Engl J Med 2008;358(13):1362-9.
检索: PubMed 18367739
DOI码: 10.1056/NEJMct0708272
Clinical effectiveness of decitabine in severe sickle cell disease. (打开新窗口)
来源: Br J Haematol 2008;141(1):126-9.
检索: PubMed 18324975
DOI码: 10.1111/j.1365-2141.2008.07027.x
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (打开新窗口)
来源: Blood 2010;115(12):2354-63.
检索: PubMed 19903897
DOI码: 10.1182/blood-2009-05-221333
预防感染和其他并发症
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (打开新窗口)
来源: Cochrane Database Syst Rev 2012;(9):CD003427.
检索: PubMed 22972063
DOI码: 10.1002/14651858.CD003427.pub2
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (打开新窗口)
来源: Lancet Haematol 2021;8(5):e323-33.
检索: PubMed 33838113
DOI码: 10.1016/S2352-3026(21)00059-4
A phase 3 trial of l-glutamine in sickle cell disease. (打开新窗口)
来源: N Engl J Med 2018;379(3):226-35.
检索: PubMed 30021096
DOI码: 10.1056/NEJMoa1715971
Malaria chemoprophylaxis in sickle cell disease. (打开新窗口)
来源: Cochrane Database Syst Rev 2006;(4):CD003489.
检索: PubMed 17054173
DOI码: 10.1002/14651858.CD003489.pub2